The global erythropoietin drugs market was valued at USD 6.87 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2023 to 2030. The introduction of biosimilar EPO in the U.S. market in 2018, the impending patent expiry of Aranesp in 2024 in... Read More »
February 2023The global radiation oncology market size was valued at USD 8.65 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2030. Key factors driving the market include technological advancement in radiotherapy equipment, global rise in cancer... Read More »
February 2023The global retinal disorder treatment market size was estimated at USD 12.57 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. The retinal disorder treatment industry is witnessing growth due to factors such as the growing incide... Read More »
February 2023The global generic pharmaceuticals market was valued at USD 361.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. The growth can be attributed to the number of ANDA approvals and launches of generic drugs products is increasing... Read More »
February 2023The global cannabis cultivation market was valued at USD 392.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.3% from 2023 to 2030. Growing legalization and the adoption of cannabis for the treatment of chronic diseases are the key factors driving... Read More »
February 2023The U.S. and Europe pharmaceutical manufacturing market was valued at USD 378.51 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.81% from 2023 to 2030. The introduction of novel technologies, adoption of more efficient & cost-effective manufacturi... Read More »
January 2023The U.S. actinic keratosis treatment market size was valued at USD 2.32 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.03% from 2023 to 2030. The increasing prevalence of actinic keratosis, the increased risk of developing skin cancer, and the surg... Read More »
January 2023The global bronchodilators market size was estimated at USD 22.19 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.29% by 2030. The bronchodilators market is witnessing growth due to factors such as the growing geriatric population, increasing preval... Read More »
January 2023The global biodefense market size was valued at USD 15.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. Biodefense is a set of medical or military measures. These are taken in response to the demand for restoring the biosecuri... Read More »
December 2022The global minimal residual disease testing market was estimated at USD 1.89 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.45% from 2023 to 2030. The minimal residual disease testing market is witnessing growth due to factors such as the increasi... Read More »
December 2022The global infertility drugs market size was valued at USD 3,480.14 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The market players are engaged in introducing novel medicines for treating infertility.... Read More »
December 2022The India molecular diagnostics market size was valued at USD 934 million in 2022 and is expected to decline at a compounded annual rate of -7.49% from 2023 to 2030. The rising target disease burden, growing geriatric population, and introduction of technologically advanced products... Read More »
December 2022The Europe branded generics market size was valued at USD 38.96 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030. The rising prevalence of chronic diseases across the region is expected to contribute to market growth. The increas... Read More »
December 2022The global population screening market size was estimated at USD 25.18 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.36% from 2023 to 2030. The market is witnessing growth due to factors such as the increasing prevalence of chronic and non-communi... Read More »
December 2022The global omics lab services market size was estimated at USD 69,381.85 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.72% by 2030. The omics lab services market is witnessing growth due to the factors such as increasing demand/adoption for the s... Read More »
December 2022The global autism spectrum disorder treatment market size was valued at USD 2.05 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The research and development of novel medicines to treat patients with autism spectrum disorder (A... Read More »
December 2022The global gastrointestinal therapeutics market size was valued at USD 37.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.3% from 2023 to 2030. The increasing prevalence of gastrointestinal disorders such as IBS, Crohn’s disease, and ulcerat... Read More »
December 2022The global endometriosis treatment market size was valued at USD 1,222.2 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2023 to 2030. The rising disease burden, increasing disease awareness, and robust product pipeline are among the major ... Read More »
November 2022The global vulvovaginal candidiasis treatment market size was valued at USD 986.5 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.39% from 2022 to 2030. According to an NCBI article, VVC is a common infection among women affecting around 138 million w... Read More »
November 2022The global post-traumatic stress disorder treatment market size was valued at USD 915.5 million in 2021 and is expected to witness a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. The major factor driving the market includes robust late stage product pipeline and increasin... Read More »
November 2022